C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/88 (2006.01) A61K 31/519 (2006.01) A61P 29/00 (2006.01) C07D 401/12 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2670031
The present invention relates generally to azabicyclic containing pharmaceutical agents, and in particular, to azabicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azabicyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, which exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors.
L'invention concerne, de manière générale, des agents pharmaceutiques contenant de l'azabicyclique, et notamment des composés inhibant la métalloprotéase azabicyclique. Cette invention concerne plus particulièrement une nouvelle classe de composés inhibant les MMP-3, MMP-8 et/ou MMP-13 azabicycliques, qui offre une puissance et une sélectivité améliorées par rapport aux inhibiteurs de MMP-13, MMP-8 et MMP-3 actuellement connus.
Bosies Michael
Chevrier Carine
Deng Hongbo
Gallagher Brian M. Jr.
Gege Christian
Alantos Pharmaceuticals Holding Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Heterobicyclic metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterobicyclic metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1487393